The devotion, expertise, and degree of professionalism employed by the (Altasciences) team in all stages of development, and the support provided during the Clinical trial, were unprecedented.
Related Press Release
August 12, 2019
Altasciences is proud to announce that CEO Chris Perkin has been recognized as a 2019 Red Jacket honoree.
Safety assessments for both small and large molecules
Clinical pharmacology trials from first-in-human to end of Phase II
As part of our full service offering or as standalone solutions